MAPK1 and neoplasm: In TNBC, the overexpression of circZCCHC2 can lead to the decrease of miR‐1200 expression and the increase of TPR expression, which induces the activation of RAS–RAF–MEK–ERK cascade signaling and inhibits the sensitivity of tumor cells to pirarubicin therapy.96